Concepedia

Tobias Silzle

TS

15

Publications

913

Citations

14

H-Index

2003

Active since

Affiliations

Kantonsspital St. Gallen(Current)

University Hospital of Bern

University of St.Gallen

Erasmus MC Cancer Institute

KU Leuven

Tobias Silzle is an author at Kantonsspital St. Gallen specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

2003–2024

15

Publications

15

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro et al. · New England Journal of Medicine · 2023 · 435 citations · Full text

Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue

Tobias Silzle, Marina Kreutz, Marcus A. Dobler et al. · European Journal of Immunology · 2003 · 141 citations · Full text

, , +14

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Bob Löwenberg, Thomas Pabst, Johan Maertens et al. · Blood Advances · 2021 · 65 citations · Full text

The novel  2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells

Marianne Kraus, Jürgen Bader, Paul P. Geurink et al. · Haematologica · 2015 · 47 citations · Full text

Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis

Michael Daskalakis, Giuseppe Colucci, Peter M. Keller et al. · Cytometry Part B Clinical Cytometry · 2014 · 34 citations

Rows per page

1–5 of 15